Literature DB >> 6781685

Levodopa: long-term impact on Parkinson's disease.

D M Mann, P O Yates.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6781685      PMCID： PMC1504814          DOI： 10.1136/bmj.282.6268.985-c

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  Lipoprotein pigments--their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells.

Authors:  D M Mann; P O Yates
Journal:  Brain       Date:  1974-09       Impact factor: 13.501

2.  Neuromelanin and RNA in cells of substantia nigra.

Authors:  D M Mann; P O Yates; C M Barton
Journal:  J Neuropathol Exp Neurol       Date:  1977 Mar-Apr       Impact factor: 3.685

3.  Variations in melanin content with age in the human substantia nigra.

Authors:  D M Mann; P O Yates; C M Barton
Journal:  Biochem Exp Biol       Date:  1977

4.  Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy.

Authors:  R P Lesser; S Fahn; S R Snider; L J Cote; W P Isgreen; R E Barrett
Journal:  Neurology       Date:  1979-09       Impact factor: 9.910

5.  The impact of treatment with levodopa on Parkinson's disease.

Authors:  K M Shaw; A J Lees; G M Stern
Journal:  Q J Med       Date:  1980
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.